Information Provided By: 
Fly News Breaks for April 13, 2017
MDXG
Apr 13, 2017 | 10:38 EDT
Piper Jaffray analyst Matt O'Brien noted that MiMedx preannounced Q1 revenue of $72.6M, which topped his estimate and the consensus view. Following the announcement, he raised his FY17 revenue estimate by $1.5M and increased his price target to $12 from $10. O'Brien keeps an Overweight rating on MiMedx shares.
News For MDXG From the Last 2 Days
There are no results for your query MDXG
